These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups. Euler AR; Safdi M; Rao J; Jaszewski R; Welsh J; Le V; Raskin J; Fleischmann R; Razzaque M; Champion C Gastroenterology; 1990 Jun; 98(6):1549-57. PubMed ID: 2186951 [TBL] [Abstract][Full Text] [Related]
11. [Effect of treatment with 15/R/15-methyl derivative of prostaglandin E2 on aspirin- and indomethacin-induced damage of the mucous membrane of the upper digestive tract in rheumatoid arthritis patients]. Mach T; Bogdał J; Stachura J; Kirchmayer S Pol Tyg Lek; 1987 Sep; 42(38):1183-5. PubMed ID: 3438193 [No Abstract] [Full Text] [Related]
12. [Value of prostaglandin E1 in the treatment of cyanotic congenital heart defects in infants]. Dymnicka S; Bielińska B; Ereciński J; Machnowski W Pediatr Pol; 1981 Oct; 56(10):1243-8. PubMed ID: 7199703 [No Abstract] [Full Text] [Related]
13. Arbaprostil [15(R)-15-methyl prostaglandin E2] in a single nighttime dose of either 50 or 100 micrograms in acute duodenal ulcer. Euler AR; Bailey RJ; Zinny MA; Brandon ML; Rousseau B; Ferguson JP; Wood DR; Le VH Gastroenterology; 1989 Jul; 97(1):98-103. PubMed ID: 2656368 [TBL] [Abstract][Full Text] [Related]
14. A multiclinic trial evaluating arbaprostil [15(R)-15-methyl prostaglandin E2] as a therapeutic agent for gastric ulcer. Euler AR; Popiela T; Tytgat GN; Kulig J; Lookabaugh JL; Phan TD; Kitt MM Gastroenterology; 1989 Apr; 96(4):967-71. PubMed ID: 2647578 [TBL] [Abstract][Full Text] [Related]
15. Effects of PGE1 in murine models of SLE: changes in circulating immune complexes. Winkelstein A; Kelley VE Clin Immunol Immunopathol; 1981 Aug; 20(2):188-92. PubMed ID: 7261479 [No Abstract] [Full Text] [Related]
16. Failure of a cytoprotective dose of arbaprostil to heal acute duodenal ulcers. Results of a multiclinic trial. Euler AR; Tytgat G; Berenguer J; Brunner H; Wood DR; Lookabaugh JL; Phan TD Gastroenterology; 1987 Mar; 92(3):604-7. PubMed ID: 3545965 [TBL] [Abstract][Full Text] [Related]
17. Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study. Vantrappen G; Janssens J; Popiela T; Kulig J; Tytgat GN; Huibregtse K; Lambert R; Pauchard JP; Robert A Gastroenterology; 1982 Aug; 83(2):357-63. PubMed ID: 7044880 [TBL] [Abstract][Full Text] [Related]
18. A therapeutic trial of 15 (R)-15-methyl prostaglandin E2 in rheumatoid arthritis patients with gastroduodenal lesions. Simmons TC; Weinstein WM; Shapira M; Grossman MI Prostaglandins; 1981; 21 Suppl():165-73. PubMed ID: 7029650 [TBL] [Abstract][Full Text] [Related]
19. [Effect of prostaglandin E2 on the microvascular and cellular reactions in inflammation]. Aleksandrov PN; Speranskaia TV Patol Fiziol Eksp Ter; 1985; (4):55-7. PubMed ID: 3864122 [No Abstract] [Full Text] [Related]
20. [Experimental immune complex nephritis (2). Therapeutic effect of prostaglandin E1 and the combined effects of prostaglandin E1 and a massive dosage of the antigen on serum sickness nephritis in rats]. Nagamatsu T; Kozima R; Suzuki Y Nihon Yakurigaku Zasshi; 1983 Apr; 81(4):295-303. PubMed ID: 6224726 [No Abstract] [Full Text] [Related] [Next] [New Search]